Biologic therapy for refractory scleritis: a new treatment perspective

International Ophthalmology
Tania Sales de Alencar de FidelixVirginia Fernandes Moça Trevisani

Abstract

Scleritis is an umbrella term for a heterogeneous group of ocular diseases that can be associated with autoimmune or systemic disorders. The purpose of this article was to review the literature regarding the use of biologic drugs to treat refractory scleritis. A search of the MEDLINE, Embase, and LILACS electronic databases was conducted, and the reference lists of published articles were hand-searched. No language filters were used. This search strategy yielded no randomized trials of the use of biologic therapies to treat scleritis; only case reports and retrospective studies were retrieved. These studies suggest that monoclonal antibodies (infliximab and adalimumab) are superior to the soluble TNF receptor fusion protein etanercept for the treatment of scleritis in patients that do not respond to corticosteroids and/or to immunosuppressive treatment. Rituximab seems to be the best option for scleritis associated with vasculitis.

References

Mar 1, 1976·The British Journal of Ophthalmology·P G Watson, S S Hayreh
Aug 1, 1991·Australian and New Zealand Journal of Ophthalmology·P McCluskey, D Wakefield
Aug 10, 1999·Drugs·S V OnrustJ A Balfour
Jun 17, 2005·Annals of the Rheumatic Diseases·K Ahmadi-SimabW L Gross
Oct 20, 2005·The British Journal of Ophthalmology·C M G CheungC O S Savage
Jun 13, 2006·Clinical & Experimental Ophthalmology·Lyndell LimJustine R Smith
Aug 22, 2006·Autoimmunity Reviews·Salvatore De Vita, Luca Quartuccio
Aug 22, 2006·Autoimmunity Reviews·James S W KongM Eric Gershwin
Oct 28, 2006·Annals of the Rheumatic Diseases·J S SmolenUNKNOWN Working Group on the Rituximab Consensus Statement
Dec 7, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Ismael I AtchiaR W D Bell
Jul 11, 2007·Archives of Ophthalmology·Lucia SobrinC Stephen Foster
Aug 4, 2007·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·K WeissU Pleyer
Sep 27, 2007·The British Journal of Ophthalmology·Julie FreidlinNisha Acharya
Dec 25, 2007·Pharmacology & Therapeutics·Daniel TraceyPaul P Tak
Jan 5, 2008·Clinical & Experimental Ophthalmology·Luigi FontanaGiorgio Tassinari
May 14, 2008·Archives of Ophthalmology·Valerie P J SawSusan L Lightman
Jun 24, 2008·Ocular Immunology and Inflammation·Nancy HuynhC Stephen Foster
Nov 28, 2008·Autoimmunity Reviews·Mario García-CarrascoRicard Cervera
Mar 27, 2009·The British Journal of Ophthalmology·P A KurzJ T Rosenbaum
May 1, 2009·Arthritis and Rheumatism·Simon R J TaylorSusan L Lightman
Jun 2, 2009·Japanese Journal of Ophthalmology·Seong Joon AhnWon Ryang Wee
Jun 10, 2009·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·H Nida SenRobert B Nussenblatt
Jun 19, 2009·Journal français d'ophtalmologie·J Le GarrecF Mouriaux
Jun 26, 2009·The British Journal of Ophthalmology·S ChauhanR J Moots
Aug 13, 2009·Autoimmunity Reviews·Gabriel J TobónAlain Saraux
Sep 1, 2009·Autoimmunity Reviews·Thomas DörnerUNKNOWN International Roundtable on B cells as Therapeutic Target for Intervention
Dec 4, 2009·The British Journal of Ophthalmology·Priyanka DoctorC Stephen Foster
Feb 12, 2010·International Journal of Rheumatology·Luca QuartuccioSalvatore De Vita
Feb 16, 2010·Clinical Rheumatology·Juan P Restrepo, María P Molina
May 12, 2010·Cornea·Valentín HuervaAgustín Ruiz
May 21, 2010·Ocular Immunology and Inflammation·Mahmood Jabbarvand, Masoud Aghsaei Fard
May 21, 2010·Ocular Immunology and Inflammation·Barbara IaccheriTito Fiore
Jul 27, 2010·Autoimmunity Reviews·Maurizio BenucciFabiola Atzeni
Sep 16, 2010·Current Opinion in Ophthalmology·Aleksandra RachitskayaThomas A Albini
Nov 26, 2010·Ophthalmology·H Nida SenRobert B Nussenblatt
Feb 19, 2011·Japanese Journal of Ophthalmology·Joo Youn OhWon Ryang Wee

❮ Previous
Next ❯

Citations

Aug 24, 2016·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C TappeinerA Heiligenhaus
Mar 30, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Maxwell S StemLisa J Faia
Jan 6, 2017·Clinical Reviews in Allergy & Immunology·Jaume Alijotas-ReigJosep Maria Gris
Jul 25, 2019·Indian Journal of Ophthalmology·Parthopratim Dutta MajumderViswanath Kaushik
Jul 30, 2019·BMJ Open Ophthalmology·Chiharu IwahashiNobuyuki Ohguro
Apr 28, 2020·Cutaneous and Ocular Toxicology·S A KandarakisI Georgalas
May 28, 2019·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Dong Hyun LeeMin Kim
May 26, 2017·Ocular Immunology and Inflammation·C BottinD Saadoun
May 16, 2020·Mediators of Inflammation·Claudia FabianiLuca Cantarini
Apr 10, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Stephen P McAdoo, Charles D Pusey
Jan 11, 2021·Survey of Ophthalmology·Raul E Ruiz-LozanoAlejandro Rodriguez-Garcia
Jun 7, 2020·Experimental Eye Research·D P C VergouwenM W J Schreurs
Feb 4, 2019·Joint, Bone, Spine : Revue Du Rhumatisme·Gaëlle ClavelLuca Semerano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.